Immediate Impact

98 standout
Sub-graph 1 of 23

Citing Papers

Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy
2023 Standout
Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture
2023 Standout
3 intermediate papers

Works of Scott Baum being referenced

An open-label, single-arm, phase II clinical trial of RP1, an enhanced potency oncolytic herpes virus, combined with nivolumab in four solid tumor types: Initial results from the skin cancer cohorts.
2020
Silent deep vein thrombosis in immobilized multiple trauma patients
1989

Author Peers

Author Last Decade Papers Cites
Scott Baum 125 48 140 106 17 319
Ross Se 52 13 91 27 17 358
J Brush 134 95 133 110 13 353
Kenneth E. Najarian 160 8 99 93 13 310
Rolf‐Peter Spielmann 146 51 107 34 12 344
Coller Fa 55 52 127 162 15 359
Dominik Schramm 119 88 78 92 27 354
Maria Sofia Rosati 111 79 188 31 24 331
Richard W. Zollinger 72 65 194 27 26 296
IF Hawkins 217 27 157 21 19 331
Anant Patel 85 11 117 38 16 265

All Works

Loading papers...

Rankless by CCL
2026